Trial Profile
Safety and effectivness of directly-acting antiviral combination therapies in elderly patients (greater than 70 years): German Hepatitis C-Registry (DHC-R)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Mar 2017
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 28 Feb 2017 New trial record